Birrer, M. J., Fujiwara, K., Oaknin Benzaquen, A. M., Randall, L., Ojalvo, L. S., Valencia, C., & Ray-Coquard, I. (2022). The Changing Landscape of Systemic Treatment for Cervical Cancer: Rationale for Inhibition of the TGF-β and PD-L1 Pathways.
Citación estilo ChicagoBirrer, Michael J., Keiichi Fujiwara, Ana Mazaltob Oaknin Benzaquen, Leslie Randall, Laureen S. Ojalvo, Christian Valencia, y Isabelle Ray-Coquard. The Changing Landscape of Systemic Treatment for Cervical Cancer: Rationale for Inhibition of the TGF-β and PD-L1 Pathways. 2022.
Cita MLABirrer, Michael J., et al. The Changing Landscape of Systemic Treatment for Cervical Cancer: Rationale for Inhibition of the TGF-β and PD-L1 Pathways. 2022.
Precaución: Estas citas no son 100% exactas.